Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences has excelled in the last Research Excellence Framework (REF) results.

The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences has excelled in the last Research Excellence Framework (REF) results.

The REF assesses the quality and impact of research submitted by universities across all disciplines, with the latest results showing top-ranking for Oxford’s clinical medicine.

NDORMS submitted to the REF’s Unit of Assessment 1 - Clinical Medicine - alongside other academic departments, and contributed significantly to the excellent results of UoA1 at Oxford; the sub-panel welcomed the strong return in orthopaedic sciences, as well as the outstanding reach and significance of the impacts from research in musculoskeletal and ageing.

Professor Andrew Carr, Head of NDORMS, said: "NDORMS has made a significant contribution to the nationally top ranked submission from the University of Oxford. It is particularly gratifying to have been specifically mentioned by the assessment panel for both the quality of our publications and the impact of our research. This is a testament to the world class multidisciplinary researchers working in the department."

The results for UoA1 show Clinical Medicine at Oxford ranked top on overall REF research profile (GPA rank) using all quality scores. Overall, we were also top ranked with maximum 4* score, where 53% of overall submissions were judged to be world-leading for originality, significance and rigour, and 92% of our overall quality profile was rated as ‘world leading’ or ‘internationally excellent’. On addition, 82% of our research impacts were scored 4* - outstanding in terms of reach and significance - and 18% scored 3*.

You can see an example of how research at NDORMS significantly impacts people’s lives in this short video on fighting arthritis.

Read more on the University’s page and see the University's REF 2014 results table.

Similar stories

Oxford researchers call for an urgent re-evaluation of “weak” opioid safety profile

A new study associates dispensation doses of tramadol with increased risk of mortality, cardiovascular events, and fractures compared to the use of codeine to treat pain.

New therapeutic targets identified to treat inflammatory bowel disease

Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.

Afsie Sabokbar wins Lifetime Achievement at Teaching Excellence Awards

Director of Graduate Studies Afsie Sabokbar wins Lifetime Achievement at 2021 Teaching Excellence Awards.

NDORMS staff recognised in the 2021 Teaching Excellence Awards

Director of Graduate Studies Afsie Sabokbar, Associate Professor Stephanie Dakin and Graduate Studies Officer Samuel Burnell were all winners in the Teaching Excellence Awards.

Five ways to take action for your bone health

On World Osteoporosis Day, the International Osteoporosis Foundation (IOF), the world’s largest non-governmental organisation in the bone field, urges action for osteoporosis and fracture prevention.

NDORMS researchers awarded funding by The Paget’s Association

Professor Philippa Hulley and Doctor Helen Knowles have been awarded funding by The Paget’s Association for their research on bone cells.